Save time and get answers to complex questions with AI chat
Bortezomib market france?Allergan's patent for latisse expired?The expiration date of the key patent for guselkumab?Drugpatentwatch trametinib?What is dabrafenib mesylate msn patent issue?
See the DrugPatentWatch profile for Osimertinib
There isn’t a universal “coupon” for osimertinib (Tagrisso), but there are several ways people save on this high‑cost cancer medication. Here are the common options and how to pursue them: - Manufacturer patient assistance programs - AstraZeneca often offers Tagrisso patient support programs that can help with access and cost for eligible patients (uninsured or underinsured, and sometimes based on income). Eligibility varies. - How to pursue: visit the official Tagrisso website or contact AstraZeneca’s Patient Support Services/Access team. They can tell you what options exist and how to apply. - Co-pay cards and savings programs (for insured patients) - If you have commercial/private insurance, there may be a co-pay card or savings program to reduce out-of-pocket costs. - Important note: these programs typically aren’t available to patients with government insurance (e.g., Medicare, Medicaid) or uninsured patients. Check the terms on the official program page or ask a member of your oncology team. - Insurance navigation and prior authorization - Your oncologist, infusion/office staff, or a dedicated pharmacist can help with prior authorization, verify coverage, and see if any step therapy or alternatives apply. - Sometimes the insurer will cover a large portion after the necessary paperwork is completed; your care team can guide you. - Nonprofit and foundation assistance - Organizations like the PAN Foundation, CancerCare, NeedyMeds, and other patient assistance groups may help with copays or costs not covered by insurance. - They require income and insurance documentation and sometimes a physician’s referral or proof of medical necessity. - Clinical trials - Depending on your location and eligibility, a clinical trial may provide access to osimertinib at no cost. - Talk with your oncologist about any trials that might be a fit. What I can do next - Tell me your country and whether you have insurance (and what type). I can point you to the closest official patient-support pages, contact numbers for the manufacturer, and relevant nonprofit programs. - If you’d like, I can also help you draft a checklist or questions to bring to your clinic to get the most out of each option.
Other Questions About Osimertinib :